Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT07264647 · RECRUITING

Trial details

NCT number: NCT07264647
Sponsor: Fondazione Ricerca Traslazionale
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III NSCLC

Start date: 2025-03-27
Primary completion: 2028-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.